RSHL1 Activators
RSHL1 employ a variety of mechanisms to initiate its activation, primarily through the modulation of intracellular cyclic AMP (cAMP) levels or through stress-activated protein kinase pathways. For instance, Forskolin, Isoproterenol, PGE1, PGE2, Epinephrine, Glucagon, Terbutaline, and Dobutamine all function by directly or indirectly stimulating adenylate cyclase, which subsequently increases cAMP levels within the cell. An increase in cAMP activates protein kinase A (PKA). Once activated, PKA can phosphorylate RSHL1, leading to its activation. Additionally, compounds like IBMX and Rolipram work by inhibiting the breakdown of cAMP, thus sustaining elevated levels of this messenger molecule within the cell, which further ensures the activation of PKA, and consequently the phosphorylation of RSHL1.
Sp-8-Br-cAMPS, a cAMP analog, bypasses the typical receptor-mediated activation process and directly activates PKA, streamlining the pathway to RSHL1 activation. On the other hand, Anisomycin follows a distinct pathway; it activates stress-activated protein kinases such as JNK, which, despite its primary role as a protein synthesis inhibitor, may lead to the phosphorylation and activation of RSHL1 through stress response mechanisms. This diverse arsenal of chemicals, by variously increasing cAMP levels or activating kinases, ensures multiple routes through which RSHL1 can be activated within the cellular environment. Each activator, by engaging with specific receptors or cellular processes, converges on the common endpoint of RSHL1 activation, highlighting the intricate network of intracellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases intracellular cAMP levels through the activation of adenylyl cyclase. The rise in cAMP activates PKA, which in turn can phosphorylate RSHL1, leading to its activation. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Prostaglandin E1 binds to its receptor, leading to increased intracellular cAMP production via adenylate cyclase activation. The consequent PKA activation could lead to the phosphorylation and activation of RSHL1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and thereby maintains high levels of cAMP in the cell. This can lead to PKA activation and subsequent phosphorylation and activation of RSHL1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that, paradoxically, activates stress-activated protein kinases like JNK, which could phosphorylate and activate RSHL1 as part of the cellular stress response. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to increased cAMP levels, which in turn activates PKA. PKA can then phosphorylate RSHL1, resulting in its activation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages beta-adrenergic receptors, causing a rise in intracellular cAMP levels. The subsequent activation of PKA can lead to the phosphorylation and activation of RSHL1. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 interacts with its specific receptors, leading to increased cAMP production and activation of PKA. Activated PKA is capable of phosphorylating RSHL1, which results in its activation. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline is a beta2-adrenergic agonist that increases cAMP levels by stimulating adenylyl cyclase. The resulting PKA activation can lead to phosphorylation and activation of RSHL1. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
Dobutamine is a beta1-adrenergic agonist that can increase cAMP production, leading to PKA activation. PKA then has the potential to phosphorylate and activate RSHL1. | ||||||